Moonshot
inside pfizer's nine-month race to make the impossible possible
$40.01
- Hardcover
288 pages
- Release Date
5 July 2022
Summary
Moonshot: The Race to Conquer Covid-19
The exclusive, first-hand, behind-the-scenes story of how Pfizer raced to create the first Covid-19 vaccine, told by Pfizer’s CEO Dr. Albert Bourla
A riveting, fast-paced, inside look at one of the most incredible private sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr. Albert Bourla, made “the impossible pos…
Book Details
| ISBN-13: | 9780008503987 |
|---|---|
| ISBN-10: | 0008503982 |
| Author: | Albert Bourla |
| Publisher: | HarperCollins Publishers |
| Imprint: | HarperCollins |
| Format: | Hardcover |
| Number of Pages: | 288 |
| Release Date: | 5 July 2022 |
| Weight: | 510g |
| Dimensions: | 240mm x 159mm x 26mm |
About The Author
Albert Bourla
Dr. Albert Bourla became Pfizer CEO in January 2019. He began his career at the company in 1993, in the Animal Health Division as Technical Director of Greece, and has served in numerous executive positions within the company, including Chief Operating Officer, Group President of Pfizer Innovative Health, and Group President of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business. He is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University.
In addition to his responsibilities at Pfizer, Dr. Bourla is on the executive committee of The Partnership for New York City, a director on multiple boards, including Pfizer, Inc., PhRMA, and Catalyst, a Trustee of the United States Council for International Business, and a member of the Business Roundtable and the Business Council. In 2020, Dr. Bourla was named America’s top CEO in the Pharmaceuticals sector by Institutional Investor magazine.
Returns
This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.